We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
 

Latest News

Researchers Link ‘Epigenetic’ Changes to Inflammation-Induced Colon Cancer
News   Dec 08, 2011

Johns Hopkins Kimmel Cancer Center scientists report that sharp rises in levels of reactive oxygen molecules, and the inflammation that results, trigger biochemical changes that silence genes in a pattern often seen in cancer cells. The researchers confirmed this gene-silencing effect in mice that develop inflammation-induced colon cancer.

READ MORE

Expansion of Genome Research will Benefit Two Boston-area Research Centers
News   Dec 07, 2011

Federal health officials announced an expanded investment in understanding the genetic underpinnings of disease, and two Boston-area institutions will share in the funding to do basic research and answer emerging questions about the social, ethical, and financial repercussions of using genomics in standard medicine.

READ MORE

Using Epigenetics in Lung Cancer
News   Dec 07, 2011

In a paper published in Cancer Discovery, researchers have used epigenetic therapy to target non-small cell lung cancer (NSCLC) by switching silenced genes back on.

READ MORE

Epigenetic MGMT Test Enters Phase III Brain Cancer Study
News   Dec 07, 2011

MDxHealth announced it has entered into a companion diagnostic agreement with Prof. Dr. Ulrich Herrlinger of the Division of Clinical Neuro-oncology of the University Hospital of Bonn (Germany) to provide MGMT epigenetic testing.

READ MORE

TRACON Pharmaceuticals Announces Appointment of Kenneth Galbraith as Chairman of the Board
News   Dec 07, 2011

The privately held biopharmaceutical company, which focuses on the development of cancer therapeutics, announced the appointment of Kenneth Galbraith as Chairman of the Board.

READ MORE

TetraLogic Pharmaceuticals Announces Clinical Trial
News   Dec 06, 2011

The biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, declared the initiation of a Phase 1/2 clinical trial of its lead Smac mimetic drug candidate, TL32711, in elderly patients with acute myelogenous leukemia (AML).

READ MORE

Gene Rearrangements Linked to Breast Cancer
News   Dec 06, 2011

Alterations behind seven percent of all breast cancers Identified. Two other rearrangements associated with prostate and lung cancer could also be behind five to seven percent of all breast cancers, according to US scientists.

READ MORE

Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Combination Study
News   Dec 02, 2011

The company announced the first patient has been dosed in the study, which combines MM-121, a fully human monoclonal antibody that targets ErbB3, with one of multiple anticancer therapies for patients with advanced solid tumors.

READ MORE

TGen Seek Pancreatic-Cancer Patients for Trial
News   Dec 01, 2011

The Translational Genomics Research Institute is seeking 34 pancreatic-cancer patients at four sites around the country to participate in clinical trials that officials hope will bring them closer to a cure.

READ MORE

mRNA Profile Independently Predicts Prostate Cancer Prognosis
News   Nov 30, 2011

Scientists have found that classifying prostate tumors according to their mRNA expression patterns can help predict disease aggressiveness and poor prognosis in patients with low- or mid-range Gleason scores.

READ MORE

 
Advertisement